Work

Deciphering the anticancer mechanisms of sunitinib

Year: 2010

Type: article

Abstract: Commentary to: SU11248, A selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cellsEmily Young, Lucio Miele, Kevan B Tucker, Min Huang, Jeremy Wells and Jian-Wei Gu

Source: Cancer Biology & Therapy

DOI: 10.4161/cbt.10.7.13130

Authors: Sumanta Kumar Pal, Robert A. Figlin, Hua Yu

Institutions: City of Hope, Cedars-Sinai Medical Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: California Breast Cancer Research Program, National Institutes of Health, National Cancer Institute